334 related articles for article (PubMed ID: 24497229)
1. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Bhatt J
Cochrane Database Syst Rev; 2014 Feb; (2):CD002009. PubMed ID: 24497229
[TBL] [Abstract][Full Text] [Related]
2. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Bhatt J; Nevitt SJ
Cochrane Database Syst Rev; 2017 Mar; 3(3):CD002009. PubMed ID: 28349527
[TBL] [Abstract][Full Text] [Related]
3. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Bhatt J; Jahnke N; Smyth AR
Cochrane Database Syst Rev; 2019 Sep; 9(9):CD002009. PubMed ID: 31483853
[TBL] [Abstract][Full Text] [Related]
4. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Bhatt J
Cochrane Database Syst Rev; 2010 Jan; (1):CD002009. PubMed ID: 20091528
[TBL] [Abstract][Full Text] [Related]
5. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Tan KH
Cochrane Database Syst Rev; 2006 Jul; (3):CD002009. PubMed ID: 16855982
[TBL] [Abstract][Full Text] [Related]
6. Once-daily versus multiple-daily dosing with intravenous aminoglycosides for cystic fibrosis.
Smyth AR; Bhatt J
Cochrane Database Syst Rev; 2012 Feb; (2):CD002009. PubMed ID: 22336782
[TBL] [Abstract][Full Text] [Related]
7. Once daily versus multiple daily dosing with intravenous aminoglycosides for cystic fibrosis.
Tan K; Bunn H
Cochrane Database Syst Rev; 2000; (4):CD002009. PubMed ID: 11034740
[TBL] [Abstract][Full Text] [Related]
8. Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.
Elphick HE; Scott A
Cochrane Database Syst Rev; 2016 Dec; 12(12):CD002007. PubMed ID: 27907224
[TBL] [Abstract][Full Text] [Related]
9. Single versus combination intravenous anti-pseudomonal antibiotic therapy for people with cystic fibrosis.
Holland P; Jahnke N
Cochrane Database Syst Rev; 2021 Jun; 6(6):CD002007. PubMed ID: 34159577
[TBL] [Abstract][Full Text] [Related]
10. Extended-interval aminoglycoside administration for children: a meta-analysis.
Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
[TBL] [Abstract][Full Text] [Related]
11. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis.
Elphick HE; Jahnke N
Cochrane Database Syst Rev; 2014 Apr; (4):CD002007. PubMed ID: 24788768
[TBL] [Abstract][Full Text] [Related]
12. Single versus combination intravenous antibiotic therapy for people with cystic fibrosis.
Elphick HE; Tan A
Cochrane Database Syst Rev; 2005 Apr; (2):CD002007. PubMed ID: 15846627
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic adjuvant therapy for pulmonary infection in cystic fibrosis.
Hurley MN; Smith S; Forrester DL; Smyth AR
Cochrane Database Syst Rev; 2020 Jul; 7(7):CD008037. PubMed ID: 32671834
[TBL] [Abstract][Full Text] [Related]
14. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Smith S; Rowbotham NJ; Charbek E
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD008319. PubMed ID: 30376155
[TBL] [Abstract][Full Text] [Related]
15. Oral non-steroidal anti-inflammatory drug therapy for lung disease in cystic fibrosis.
Lands LC; Stanojevic S
Cochrane Database Syst Rev; 2016 Apr; 4():CD001505. PubMed ID: 27055154
[TBL] [Abstract][Full Text] [Related]
16. Antibiotic strategies for eradicating Pseudomonas aeruginosa in people with cystic fibrosis.
Langton Hewer SC; Smyth AR
Cochrane Database Syst Rev; 2014 Nov; (11):CD004197. PubMed ID: 25383937
[TBL] [Abstract][Full Text] [Related]
17. Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis.
Smith S; Rowbotham NJ; Charbek E
Cochrane Database Syst Rev; 2022 Aug; 8(8):CD008319. PubMed ID: 35914011
[TBL] [Abstract][Full Text] [Related]
18. Duration of intravenous antibiotic therapy in people with cystic fibrosis.
Plummer A; Wildman M
Cochrane Database Syst Rev; 2013 May; (5):CD006682. PubMed ID: 23728662
[TBL] [Abstract][Full Text] [Related]
19. Combination antimicrobial susceptibility testing for acute exacerbations in chronic infection of Pseudomonas aeruginosa in cystic fibrosis.
Waters V; Ratjen F
Cochrane Database Syst Rev; 2017 Jun; 6(6):CD006961. PubMed ID: 28628280
[TBL] [Abstract][Full Text] [Related]
20. Oral anti-pseudomonal antibiotics for cystic fibrosis.
Remmington T; Jahnke N; Harkensee C
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD005405. PubMed ID: 27412131
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
